Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
WO2085 vs Estriol Cream for Vulvovaginal Dryness
NCT03044652Phase 4Completed
- Sponsor
- Dr. August Wolff
- Start
- Nov 2016
- Primary completion
- Jun 2017
- Countries
- 2
01
Overview
Phase 4, randomised, open-label trial (2 arms), sponsored by Dr. August Wolff. Primary endpoint: Change from Baseline Total Severity Score of the Treatment of 'vulvovaginal dryness' at 6 weeks. Started Nov 2016; status: completed.
Beyond the preview
Go deeper on NCT03044652.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03044652.